95 related articles for article (PubMed ID: 1797443)
1. Conformational analysis of [n-demethyl-Tyr(OCH3)-3]RA-VII, conformationally restricted model approach.
Itokawa H; Saitou K; Morita H; Takeya K
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2161-3. PubMed ID: 1797443
[No Abstract] [Full Text] [Related]
2. Structures and conformations of metabolites of antitumor cyclic hexapeptides, RA-VII and RA-X.
Itokawa H; Saitou K; Morita H; Takeya K; Yamada K
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):2984-9. PubMed ID: 1477912
[TBL] [Abstract][Full Text] [Related]
3. Key analogues of the tetrapeptide subunit of RA-VII and deoxybouvardin.
Boger DL; Zhou J
Bioorg Med Chem; 1996 Oct; 4(10):1597-603. PubMed ID: 8931929
[TBL] [Abstract][Full Text] [Related]
4. Key analogs of the tetrapeptide subunit of RA-VII and deoxybouvardin.
Boger DL; Zhou J; Winter B; Kitos PA
Bioorg Med Chem; 1995 Dec; 3(12):1579-93. PubMed ID: 8770383
[TBL] [Abstract][Full Text] [Related]
5. Solution forms of an antitumor cyclic hexapeptide, RA-VII in dimethyl sulfoxide-d6 from nuclear magnetic resonance studies.
Itokawa H; Morita H; Takeya K
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1050-2. PubMed ID: 1525934
[TBL] [Abstract][Full Text] [Related]
6. RA-XXV and RA-XXVI, Bicyclic Hexapeptides from Rubia cordifolia L.: Structure, Synthesis, and Conformation.
Hitotsuyanagi Y; Hirai M; Odagiri M; Komine M; Hasuda T; Fukaya H; Takeya K
Chem Asian J; 2019 Jan; 14(1):205-215. PubMed ID: 30393964
[TBL] [Abstract][Full Text] [Related]
7. Aza-cycloisodityrosine analogue of RA-VII, an antitumor bicyclic hexapeptide.
Hitotsuyanagi Y; Miyazawa A; Hinosawa TA; Nakagawa Y; Hasuda T; Takeya K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6728-31. PubMed ID: 24268554
[TBL] [Abstract][Full Text] [Related]
8. Per-N-methylated analogues of an antitumor bicyclic hexapeptide RA-VII.
Hitotsuyanagi Y; Lee JE; Kato S; Kim IH; Kohashi H; Fukaya H; Takeya K
Bioorg Med Chem; 2011 Apr; 19(7):2458-63. PubMed ID: 21382716
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of [L-Ala-1]RA-VII, [D-Ala-2]RA-VII, and [D-Ala-4]RA-VII by epimerization of RA-VII, an antitumor bicyclic hexapeptide from Rubia plants, through oxazoles.
Hitotsuyanagi Y; Sasaki S; Matsumoto Y; Yamaguchi K; Itokawa H; Takeya K
J Am Chem Soc; 2003 Jun; 125(24):7284-90. PubMed ID: 12797802
[TBL] [Abstract][Full Text] [Related]
10. Cyclic peptides from higher plants. XXVIII. Antitumor activity and hepatic microsomal biotransformation of cyclic pentapeptides, astins, from Aster tataricus.
Morita H; Nagashima S; Uchiumi Y; Kuroki O; Takeya K; Itokawa H
Chem Pharm Bull (Tokyo); 1996 May; 44(5):1026-32. PubMed ID: 8689717
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of [Gly-1]RA-VII, [Gly-2]RA-VII, and [Gly-4]RA-VII. Glycine-containing analogues of RA-VII, an antitumor bicyclic hexapeptide from Rubia plants.
Hitotsuyanagi Y; Hasuda T; Aihara T; Ishikawa H; Yamaguchi K; Itokawa H; Takeya K
J Org Chem; 2004 Mar; 69(5):1481-6. PubMed ID: 14987000
[TBL] [Abstract][Full Text] [Related]
12. Conformational recognition of RA-XII by 80S ribosomes: a differential line broadening study in 1H NMR spectroscopy.
Morita H; Yamamiya T; Takeya K; Itokawa H; Sakuma C; Yamada J; Suga T
Chem Pharm Bull (Tokyo); 1993 Apr; 41(4):781-3. PubMed ID: 8508481
[TBL] [Abstract][Full Text] [Related]
13. Influence of conformational flexibility on biological activity in cyclic astin analogues.
Saviano G; Benedetti E; Cozzolino R; De Capua A; Laccetti P; Palladino P; Zanotti G; Amodeo P; Tancredi T; Rossi F
Biopolymers; 2004; 76(6):477-84. PubMed ID: 15372484
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of a bis(cycloisodityrosine) analogue of RA-VII, an antitumor bicyclic hexapeptide.
Lee JE; Hitotsuyanagi Y; Nakagawa Y; Kato S; Fukaya H; Takeya K
Bioorg Med Chem Lett; 2008 Dec; 18(24):6458-61. PubMed ID: 18993061
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of [Tyr-5-Ψ(CH2NMe)-Tyr-6]RA-VII, a reduced peptide bond analogue of RA-VII, an antitumor bicyclic hexapeptide.
Hasuda T; Hitotsuyanagi Y; Shinada M; Takeya K
Bioorg Med Chem Lett; 2012 Apr; 22(8):2757-9. PubMed ID: 22460024
[TBL] [Abstract][Full Text] [Related]
16. Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides.
Matsui K; Kido Y; Watari R; Kashima Y; Yoshida Y; Shuto S
Chemistry; 2017 Mar; 23(13):3034-3041. PubMed ID: 27878880
[TBL] [Abstract][Full Text] [Related]
17. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
[TBL] [Abstract][Full Text] [Related]
18. Astins A and B, antitumor cyclic pentapeptides from Aster tataricus.
Morita H; Nagashima S; Takeya K; Itokawa H
Chem Pharm Bull (Tokyo); 1993 May; 41(5):992-3. PubMed ID: 8339347
[TBL] [Abstract][Full Text] [Related]
19. Conformationally restricted paclitaxel analogues: macrocyclic mimics of the "hydrophobic collapse" conformation.
Boge TC; Wu ZJ; Himes RH; Vander Velde DG; Georg GI
Bioorg Med Chem Lett; 1999 Oct; 9(20):3047-52. PubMed ID: 10571173
[TBL] [Abstract][Full Text] [Related]
20. Warfarin-stereochemical aspects of its metabolism by rat liver microsomes.
Pohl LR; Nelson SD; Porter WR; Trager WF; Fasco MJ; Baker FD; Fenton JW
Biochem Pharmacol; 1976 Oct; 25(19):2153-62. PubMed ID: 971329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
